Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Blood Advances|December 24, 2019
The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemiaSina Al-Kershi, Raj Bhayadia, Michelle Ng, et al.
Nucleic Acids Research|December 22, 2017
Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applicationsMaurice Labuhn, Felix F Adams, Michelle Ng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2012
Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemiaDirk Heckl, Adrian Schwarzer, Reinhard Haemmerle, et al.
International Journal of Molecular Sciences|September 10, 2021
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AMLJacob Jalil Hassan, Anna Lieske, Nicole Dörpmund, et al.
Retrovirology|October 20, 2017
Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cellsFranziska K Geis, Melanie Galla, Dirk Hoffmann, et al.
Biomaterials|February 18, 2014
All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinaseTobias Maetzig, Johannes Kuehle, Adrian Schwarzer, et al.
Retrovirology|June 2, 2017
Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cellsFranziska K Geis, Melanie Galla, Dirk Hoffmann, et al.
Pageof 5